Evaluation of Oralair® in real conditions of use FRESH-PEF73297-en Cécile DROZ-PERROTEAU Evaluation of Oralair® in real conditions of use EVORA FRESH-PEF73297-en 73297 FRESH-PEF73297 Patrick BLIN Mathieu MOLIMARD UNIVERSITE DE BORDEAUX Epidemiology France Portal (PEF) STALLERGENES GREER (FRANCE) null Patrick;BLIN Mathieu;MOLIMARD Bordeaux PharmacoEpi Platform Grass pollen Adults and children Prospective cohort Allergic rhinitis with or without conjunctivitis Oralair Department of Medical Pharmacology General medicine Otolaryngology Paediatrics Pulmonary medicine Allergology Diseases of the respiratory system Behavioral determinants Healthcare system determinants: Use of care Healthcare system determinants Describe the prescription details of Oralair®: indication, dosage, date of introduction of the treatment with respect to the pollen season, concomitant treatments, in particular antihistamines, local corticosteroids, cromones and decongestants. null France Individuals Patients population Male Female Child (6 to 12 years) Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Patient initiating a treatment with Oralair® for the next pollen season, Patient not previously treated with Oralair®. Refusal to participate,Patient not living in the area or expected to move during the study period,Patient with a language barrier (unable to read the newsletter or complete self-questionnaires)Patient participating in a therapeutic clinical trial Clinical data Participant-reported health data Biological data Socio-demographic data Health event/morbidity Health care consumption and services Quality of life/health perception Other Administrative database (employees pupils students etc.) [500-1000[ individuals Self-administered questionnaire Interview with the participant (including clinical) Observational Study Observational Study Cohort study 525 patients (311 adults and 214 children) Unknown Restricted access The terms of access to the database must be established by a request to the study’s scientific advisory board. Ownership of and access to the study data were the subject of an agreement between the Université de Bordeaux and the laboratory. Access on specific project only